Mullins Kevin Michael 4
4 · LifeStance Health Group, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Mullins Kevin Michael
Chief Development Officer
Transactions
- Sale
Common Stock
2024-03-14$6.33/sh−44,540$281,938→ 4,745,352 total
Footnotes (1)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.